Last updated
Revenue
R&D Expenses
Operating CF
Total Assets
Total Liabilities
Equity
Shares Out.
D/E Ratio
Dilution Watch
Last traded Sep 19, 2025. This price is not current.
FDA decisions, readouts and PDUFA dates · scored by probability of approval
| Catalyst | Drug / Treatment | Stage | Prob. of Approval | Description | Drug Type | Therapeutic Area | Source |
|---|
Dated clinical, regulatory and corporate events for LakeShore Biopharma Co., Ltd
How LSB actually traded into and out of each decision
| Date | Drug | Catalyst | Stage | Reaction | Event Move % | Best Trade % |
|---|---|---|---|---|---|---|
| 2025-12-31 | YSJA™ rabies vaccine (simplified four-dose regimen) | Phase 3 data readout | Phase 3 |
| Drug | Indication | Phase | PTRS | rNPV | Status | Enroll | Velocity | Design | Est. Completion | ML Signal | Last Change |
|---|---|---|---|---|---|---|---|---|---|---|---|
| PIKA COVID-19 Vaccine VaccinesCompletedNCT05463419 | Covid-19 Vaccine | Phase 2/3 | COMPLETED | 5,860 | Apr 11, 2024 | ||||||
| PIKA COVID-19 Vaccine VaccinesCompletedNCT05305300 | COVID-19 Pandemic | Phase 1 | COMPLETED | 135 | Sep 15, 2022 |
Readouts, endpoints and source filings for every LSB program
| Drug Name | Indication | Phase | Date | Trial Results Summary | Title | Source |
|---|---|---|---|---|---|---|
| PIKA Rabies Vaccine | rabies virus infection | Phase 3 | 2024-04-09 | RVNA seroconversion rate: twice that of the comparator by Day 7Read More | YS Biopharma Announces Positive Interim Results of Pivotal Phase 3 Clinical Study of PIKA Rabies Vaccine GAITHERSBURG, Md.Read More |
| Insider | Side | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| No insider trades match the selected filters. | |||||
| Fund | % of Portfolio | Current MV | Shares Owned | Activity |
|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 0 % | 55.90 K | 54.80 K | -60.98% ( -85.63 K) |
Shares sold short, counted twice a month.
| Expiry | Call Vol | Put Vol | Vol P/C | Call OI | Put OI | OI P/C | IV Call | IV Call OI-Wtd | IV Call Vol-Wtd | IV Put | IV Put OI-Wtd | IV Put Vol-Wtd |
|---|
| Calls | Strike | Puts | ||||
|---|---|---|---|---|---|---|
| Last | Vol | OI | Last | Vol | OI | |
| No data available | ||||||
How LSB ranks across every disease it competes in